| Sean Patrick Mclaughlin, MD | |
|
6420 Nw 9th Blvd, Gainesville, FL 32605-4203 | |
| (352) 331-2332 | |
| (352) 331-6515 |
| Full Name | Sean Patrick Mclaughlin |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 23 Years |
| Location | 6420 Nw 9th Blvd, Gainesville, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669415667 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | SM087685 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tennova Healthcare-clarksville | Clarksville, TN | Hospital |
| Lake City Medical Center | Lake city, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Clarksville Physician Services Gp | 0547276917 | 24 |
News Archive
ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, today announced that it has contracted with the clinical research organization (CRO) Averion International Corp. to conduct its planned Phase II study of ICT-107, the Company's lead cancer-vaccine candidate for the treatment of glioblastoma multiforme (GBM).
After exposure to extreme life stresses, what distinguishes the individuals who do and do not develop posttraumatic stress disorder (PTSD)? A new study, published in the October 1st issue of Biological Psychiatry, suggests that it has something to do with the way that we control the activity of the prefrontal cortex, a brain region thought to orchestrate our thoughts and actions.
Onset Therapeutics, a PreCision Dermatology company and a leader in the development and commercialization of novel, prescription products for the treatment of skin disorders, today announced that it has changed its corporate name to Onset Dermatologics.
A study in the April issue of Nature Genetics establishes a model that may take scientists closer to understanding how cells in the human body determine their own fate.
Epeius Biotechnologies (www.epeiusbiotech.com) announces the completion of the design engineering and construction phase of a state-of-the-art Vector Production Unit (VPU) for the commercial manufacturing of its advanced targeted genetic medicines. In accordance with an FDA Critical Path initiative, which encourages innovation and the implementation of new technological advances in GMP, CMC, aseptic processing, and quality control, the Epeius VPU is poised to launch the large-scale production of targeted genetic medicine into the 21st century.
› Verified 3 days ago
| Entity Name | Clarksville Physician Services Gp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083657829 PECOS PAC ID: 0547276917 Enrollment ID: O20060223000133 |
News Archive
ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, today announced that it has contracted with the clinical research organization (CRO) Averion International Corp. to conduct its planned Phase II study of ICT-107, the Company's lead cancer-vaccine candidate for the treatment of glioblastoma multiforme (GBM).
After exposure to extreme life stresses, what distinguishes the individuals who do and do not develop posttraumatic stress disorder (PTSD)? A new study, published in the October 1st issue of Biological Psychiatry, suggests that it has something to do with the way that we control the activity of the prefrontal cortex, a brain region thought to orchestrate our thoughts and actions.
Onset Therapeutics, a PreCision Dermatology company and a leader in the development and commercialization of novel, prescription products for the treatment of skin disorders, today announced that it has changed its corporate name to Onset Dermatologics.
A study in the April issue of Nature Genetics establishes a model that may take scientists closer to understanding how cells in the human body determine their own fate.
Epeius Biotechnologies (www.epeiusbiotech.com) announces the completion of the design engineering and construction phase of a state-of-the-art Vector Production Unit (VPU) for the commercial manufacturing of its advanced targeted genetic medicines. In accordance with an FDA Critical Path initiative, which encourages innovation and the implementation of new technological advances in GMP, CMC, aseptic processing, and quality control, the Epeius VPU is poised to launch the large-scale production of targeted genetic medicine into the 21st century.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sean Patrick Mclaughlin, MD 6420 Nw 9th Blvd, Gainesville, FL 32605-4203 Ph: (352) 331-2332 | Sean Patrick Mclaughlin, MD 6420 Nw 9th Blvd, Gainesville, FL 32605-4203 Ph: (352) 331-2332 |
News Archive
ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, today announced that it has contracted with the clinical research organization (CRO) Averion International Corp. to conduct its planned Phase II study of ICT-107, the Company's lead cancer-vaccine candidate for the treatment of glioblastoma multiforme (GBM).
After exposure to extreme life stresses, what distinguishes the individuals who do and do not develop posttraumatic stress disorder (PTSD)? A new study, published in the October 1st issue of Biological Psychiatry, suggests that it has something to do with the way that we control the activity of the prefrontal cortex, a brain region thought to orchestrate our thoughts and actions.
Onset Therapeutics, a PreCision Dermatology company and a leader in the development and commercialization of novel, prescription products for the treatment of skin disorders, today announced that it has changed its corporate name to Onset Dermatologics.
A study in the April issue of Nature Genetics establishes a model that may take scientists closer to understanding how cells in the human body determine their own fate.
Epeius Biotechnologies (www.epeiusbiotech.com) announces the completion of the design engineering and construction phase of a state-of-the-art Vector Production Unit (VPU) for the commercial manufacturing of its advanced targeted genetic medicines. In accordance with an FDA Critical Path initiative, which encourages innovation and the implementation of new technological advances in GMP, CMC, aseptic processing, and quality control, the Epeius VPU is poised to launch the large-scale production of targeted genetic medicine into the 21st century.
› Verified 3 days ago
Dr. Perinchery Narayan, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 3426 Nw 43rd St, Suite B, Gainesville, FL 32606 Phone: 352-338-2089 Fax: 352-338-1415 | |
Romano Demarco, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1600 Sw Archer Rd, Gainesville, FL 32610 Phone: 352-265-0301 Fax: 352-265-0627 | |
Dr. Victoria Yvonne Bird, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1601 Sw Archer Rd, Gainesville, FL 32608 Phone: 305-804-7461 | |
Li-ming Su, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1600 Sw Archer Rd, Gainesville, FL 32610 Phone: 352-273-6815 Fax: 352-273-7515 | |
Dr. Lawrence Luen Shean Yeung, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1600 Sw Archer Rd, Gainesville, FL 32610 Phone: 352-273-6815 | |
Cynthia A. Sharadin, M.D. Urology Medicare: Medicare Enrolled Practice Location: 1549 Gale Lemerand Dr, Gainesville, FL 32610 Phone: 352-265-8250 Fax: 352-265-0730 | |
Dr. Vincent Gerard Bird, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1600 Sw Archer Rd, Gainesville, FL 32610 Phone: 352-273-6815 Fax: 352-273-7515 |